Ebos Group Ltd (ASX: EBO) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Ebos Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.25 billion
P/E Ratio
26.98
Dividend Yield
2.75%
Shares Outstanding
201.64 million
Earnings per share
1.408
Dividend per share
0.96
Year To Date Return
7.09%
Earnings Yield
3.71%
Franking
-
Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Should you invest $1,000 in St Barbara Limited right now?
Before you buy St Barbara Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 30 April 2025
Ebos Group Ltd (ASX: EBO)
Latest News
Capital Raising
Here's why the EBOS (ASX:EBO) share price is climbing today
Mergers & Acquisitions
EBOS (ASX:EBO) share price on watch amid cap raise and $1 billion acquisition
Share Market News
ASX 200 falls, Metcash down, 4DMedical drops
Share Market News
EBOS (ASX:EBO) share price on watch after dividend surge
Share Market News
ASX 200 rose 1.6%
Best ASX Shares
3 top ASX share picks for 2021 from NZ brokers
Healthcare Shares
EBOS share price dips on slow FY19 earnings growth
Share Market News
5 things to watch on the ASX on Thursday
Share Fallers
The 3 stocks with the biggest increase in short-selling interest over the week
Investing
Are these beaten down ASX shares too cheap to ignore?
Investing
Why these 4 ASX shares are starting the week on a high
Investing
Why the Sigma Healthcare Ltd (ASX:SIG) share price crashed 40% today
Frequently Asked Questions
-
Yes, EBOS Group has historically paid two partially franked shareholder dividends a year.
-
EBOS Group generally pays its shareholder dividends in March and September.
-
Yes, EBOS has a dividend reinvestment plan to allow shareholders to reinvest all or part of their dividends.
-
EBOS Group Ltd listed on the ASX on 6 September 2013.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 27 Feb 2025 | $0.0251 | 0.00% | Supplemental | 21 Mar 2025 |
| 29 Aug 2024 | $0.5043 | 0.00% | Final | 18 Sep 2024 |
| 29 Feb 2024 | $0.1510 | 0.00% | Supplemental | 22 Mar 2024 |
| 07 Sep 2023 | $0.0251 | 0.00% | Supplemental | 29 Sep 2023 |
| 07 Sep 2023 | $0.4705 | 0.00% | Final | 29 Sep 2023 |
| 02 Mar 2023 | $0.0234 | 0.00% | Supplemental | 17 Mar 2023 |
| 02 Mar 2023 | $0.4259 | 0.00% | Interim | 17 Mar 2023 |
| 08 Sep 2022 | $0.0216 | 0.00% | Supplemental | 30 Sep 2022 |
| 08 Sep 2022 | $0.3800 | 0.00% | Final | 30 Sep 2022 |
| 03 Mar 2022 | $0.0207 | 0.00% | Supplemental | 18 Mar 2022 |
| 03 Mar 2022 | $0.3917 | 0.00% | Interim | 18 Mar 2022 |
| 09 Sep 2021 | $0.0203 | 0.00% | Supplemental | 24 Sep 2021 |
| 09 Sep 2021 | $0.3953 | 0.00% | Final | 24 Sep 2021 |
| 04 Mar 2021 | $0.0188 | 0.00% | Supplemental | 18 Mar 2021 |
| 04 Mar 2021 | $0.3506 | 0.00% | Interim | 18 Mar 2021 |
| 24 Sep 2020 | $0.0176 | 0.00% | Supplemental | 09 Oct 2020 |
| 24 Sep 2020 | $0.3289 | 0.00% | Final | 09 Oct 2020 |
| 12 Mar 2020 | $0.0165 | 0.00% | Supplemental | 03 Apr 2020 |
| 12 Mar 2020 | $0.3232 | 0.00% | Interim | 03 Apr 2020 |
| 26 Sep 2019 | $0.0163 | 0.00% | Supplemental | 11 Oct 2019 |
| 26 Sep 2019 | $0.3076 | 0.00% | Final | 11 Oct 2019 |
| 14 Mar 2019 | $0.0152 | 0.00% | Supplemental | 05 Apr 2019 |
| 14 Mar 2019 | $0.2920 | 0.00% | Interim | 05 Apr 2019 |
| 27 Sep 2018 | $0.2871 | 0.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0146 | 0.00% | Supplemental | 06 Apr 2018 |
| 15 Mar 2018 | $0.2766 | 0.00% | Interim | 06 Apr 2018 |
| 28 Sep 2017 | $0.0146 | 0.00% | Supplemental | 13 Oct 2017 |
| 28 Sep 2017 | $0.2664 | 0.00% | Final | 13 Oct 2017 |
| 16 Mar 2017 | $0.2453 | 0.00% | Interim | 07 Apr 2017 |
| 29 Sep 2016 | $0.2697 | 0.00% | Final | 14 Oct 2016 |
| 10 Mar 2016 | $0.2075 | 0.00% | Interim | 01 Apr 2016 |
| 30 Sep 2015 | $0.2024 | 0.00% | Final | 16 Oct 2015 |
| 11 Mar 2015 | $0.1884 | 0.00% | Interim | 02 Apr 2015 |
| 01 Oct 2014 | $0.1650 | 0.00% | Final | 17 Oct 2014 |
| 12 Mar 2014 | $0.1776 | 0.00% | Interim | 04 Apr 2014 |
| 06 Apr 2011 | $0.1350 | 0.00% | Interim | 21 Apr 2011 |
| 08 Sep 2010 | $0.1750 | 0.00% | Final | 08 Oct 2010 |
| 15 Mar 2010 | $0.1350 | 0.00% | Interim | 13 Apr 2010 |
| 07 Sep 2009 | $0.1450 | 0.00% | Final | 02 Oct 2009 |
| 23 Mar 2009 | $0.1050 | 0.00% | Interim | 21 Apr 2009 |
| 15 Sep 2008 | $0.0238 | 0.00% | Supplemental | 10 Oct 2008 |
| 15 Sep 2008 | $0.1350 | 0.00% | Final | 10 Oct 2008 |
| 14 Apr 2008 | $0.0168 | 0.00% | Supplemental | 09 May 2008 |
| 14 Apr 2008 | $0.0950 | 0.00% | Interim | 09 May 2008 |
| 23 Oct 2007 | $0.0229 | 0.00% | Supplemental | 26 Oct 2007 |
| 23 Oct 2007 | $0.1300 | 0.00% | Final | 26 Oct 2007 |
| 16 Apr 2007 | $0.0168 | 0.00% | Supplemental | 20 Apr 2007 |
| 16 Apr 2007 | $0.0950 | 0.00% | Interim | 20 Apr 2007 |
| 24 Oct 2006 | $0.0229 | 0.00% | Supplemental | 27 Oct 2006 |
| 24 Oct 2006 | $0.1300 | 0.00% | Final | 27 Oct 2006 |
| 03 Apr 2006 | $0.0168 | 0.00% | Supplemental | 07 Apr 2006 |
| 03 Apr 2006 | $0.0950 | 0.00% | Interim | 07 Apr 2006 |
| 03 Oct 2005 | $0.0221 | 0.00% | Supplemental | 07 Oct 2005 |
| 03 Oct 2005 | $0.1250 | 0.00% | Final | 07 Oct 2005 |
| 14 Mar 2005 | $0.0159 | 0.00% | Supplemental | 18 Mar 2005 |
| 14 Mar 2005 | $0.0900 | 0.00% | Interim | 18 Mar 2005 |
EBO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About Ebos Group Ltd
EBOS Group Ltd (ASX: EBO) is the largest pharmaceutical wholesaler and distributor across Australia, New Zealand, and Southeast Asia. The company provides pharmaceutical and wellness products to community pharmacies, public and private hospitals, day surgeries, general practices, aged care facilities, and specialist clinics.
EBOS Group also operates an animal health product wholesale, manufacturing, and retail business, as well as providing third-party logistics services.
The vast majority of the company's revenue derives from its services to community pharmacies and institutional healthcare providers, which accounts for about 80% of revenue. Its Australian operations similarly contribute around 80% of its total revenue.
EBO Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 May 2025 | $35.94 | $0.92 | 2.63% | 24,965 | $34.90 | $35.94 | $34.89 |
| 08 May 2025 | $35.02 | $-0.02 | -0.06% | 40,082 | $34.94 | $35.17 | $34.84 |
| 07 May 2025 | $35.04 | $0.29 | 0.83% | 52,934 | $34.44 | $35.34 | $34.44 |
| 06 May 2025 | $34.75 | $-0.01 | -0.03% | 88,412 | $34.54 | $34.82 | $34.46 |
| 05 May 2025 | $34.76 | $-0.19 | -0.54% | 26,898 | $34.91 | $34.97 | $34.56 |
| 02 May 2025 | $34.95 | $0.45 | 1.30% | 59,766 | $34.49 | $34.95 | $34.35 |
| 01 May 2025 | $34.50 | $0.30 | 0.88% | 68,205 | $34.04 | $34.60 | $33.76 |
| 30 Apr 2025 | $34.20 | $0.03 | 0.09% | 74,310 | $34.20 | $34.48 | $33.64 |
| 29 Apr 2025 | $34.17 | $0.19 | 0.56% | 78,257 | $33.91 | $34.40 | $33.75 |
| 28 Apr 2025 | $33.98 | $-0.32 | -0.93% | 52,776 | $34.00 | $34.38 | $33.84 |
| 24 Apr 2025 | $34.30 | $0.00 | 0.00% | 33,471 | $34.43 | $34.51 | $34.18 |
| 23 Apr 2025 | $34.30 | $0.08 | 0.23% | 45,130 | $34.45 | $34.57 | $34.07 |
| 22 Apr 2025 | $34.22 | $-0.28 | -0.81% | 191,921 | $34.41 | $34.41 | $34.03 |
| 17 Apr 2025 | $34.50 | $0.25 | 0.73% | 42,901 | $34.13 | $34.68 | $34.13 |
| 16 Apr 2025 | $34.25 | $-0.35 | -1.01% | 41,133 | $34.40 | $34.54 | $33.99 |
| 15 Apr 2025 | $34.60 | $0.39 | 1.14% | 68,685 | $34.27 | $34.71 | $34.06 |
| 14 Apr 2025 | $34.21 | $0.25 | 0.74% | 78,680 | $34.02 | $34.41 | $33.89 |
| 11 Apr 2025 | $33.96 | $-1.58 | -4.45% | 126,022 | $33.87 | $34.13 | $33.36 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 21 Mar 2025 | Stuart McLauchlan | Issued | 39 | $1,442 |
Dividend Reinvestment Plan (DRP). NZ$
|
| 18 Sep 2024 | Stuart McLauchlan | Issued | 43 | $1,482 |
Dividend Reinvestment Plan (DRP). NZ$
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Elizabeth(Liz) Mary Coutts | Non-Executive DirectorNon-Executive Chairman | Nov 2013 |
Ms Coutts is member of the Risk Committee. She is Chair of Oceania Healthcare Limited and 2degrees Group Limited, Director of EBOS Group subsidiaries in New Zealand and Member, Marsh New Zealand Advisory Board.
|
| Mr Mark Alan Bloom | Non-Executive Director | Sep 2022 |
Mr Bloom is a member of the Risk Committee. He is a former director of Pacific Smiles Group Limited and Abacus Property Group. Mark has also held several senior finance roles, including being CFO and executive director for insurance and financial services companies Liberty Life, South Africa and Manulife Financial, Canada.
|
| Mr Stuart McLauchlan | Non-Executive Director | Jul 2019 |
Mr McLauchlan is Chairman of the Risk Committee. He is also a governor of the New Zealand Sports Hall of Fame and a member of the Marsh New Zealand Advisory Board. He was formerly a director of Ngai Tahu Tourism Ltd.
|
| Mr Matthew Peter Muscio | Non-Executive Director | Jan 2025 |
--
|
| Dr Tracey Leigh Batten | Non-Executive Director | Jul 2021 |
Dr Batten is currently Chair of the Accident Compensation Corporation and a non-executive director of Medibank Private Limited and Nanosonics Limited. She was previously a non-executive director of National Institute of Water and Atmospheric Research, Abano Healthcare Group Limited and various other healthcare related research institutes, charities and industry and government bodies. During her executive career she was Group CEO of Imperial College Healthcare NHS Trust in the United Kingdom, Group CEO of St Vincent's Health Australia, CEO of Eastern Health and CEO of Dental Health Services Victoria.
|
| Ms Julie Tay | Non-Executive Director | May 2023 |
Ms Tay is currently a director of Sonova, a global hearing care solutions company, headquartered in Switzerland and listed on the Swiss stock exchange. She has over 30 years of experience in international executive and non-executive roles across consumer healthcare, medical devices, and digital healthcare. Julie was Senior Vice President and Managing Director, Asia Pacific, and member of the global Executive Management Committee for Align Technology. Prior to this time, she was regional head of Bayer Healthcare (Diabetes Care) in Asia Pacific and previously held senior executive roles in Asia at Johnson Diversey and Johnson & Johnson.
|
| Ms Coline McConville | Non-Executive Director | Feb 2025 |
Ms McConville joins EBOS with 20 years of governance experience across a wide range of organisations operating in different countries and industries, primarily in the UK and Europe. Ms McConville is currently a director of Kings Cross Central General Partnership and 3i Group plc and a member of the Supervisory Board of German-based Tui AG. Her previous directorships include TUI Travel, UTV Media, Travis Perkins, Fevertree Drinks, Inchcape, Wembley National Stadium, Shed Media, Halifax and HBOS. During her executive career, Ms McConville was Chief Executive Officer and Chief Operating Officer of Clear Channel Communications (now iHeartMedia Inc.) and a management consultant with McKinsey and LEK.
|
| Julie Dillon | CEO Animal Care |
-
|
|
| Matt Muscio | CEO Medical Technology |
-
|
|
| Brett Barons | CEO Symbion |
-
|
|
| Leonard Hansen | Chief Financial Officer |
-
|
|
| Mithran Naiker | Chief Information Officer |
-
|
|
| David Lewis | EGM |
-
|
|
| Simon Bunde | EGM Strategic Operations ESG and Innovation |
-
|
|
| Martin Krauskopf | EGM Strategy and Mergers and Acquisitions |
-
|
|
| Janelle Cain | General Counsel |
-
|
|
| Jacinta McCarthy | Group GM Human Resources |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Sybos Holdings Pte Limited | 36,698,002 | 18.99% |
| Custodial Services Limited | 12,863,254 | 6.66% |
| HSBC Nominees (New Zealand) Limited NZCSD | 11,945,394 | 6.18% |
| JP Morgan Chase Bank NA NZ Branch-Segregated Clients Acct NZCSD | 10,313,439 | 5.34% |
| BNP Paribas Nominees (NZ) Limited NZCSD | 10,162,902 | 5.26% |
| HSBC Nominees (New Zealand) Limited A/C State Street NZCSD | 10,031,609 | 5.19% |
| JP Morgan Nominees Australia Limited | 9,884,811 | 5.12% |
| TEA Custodians Limited Client Property Trust Account NZCSD | 7,607,290 | 3.94% |
| Forsyth Barr Custodians Limited | 6,814,524 | 3.53% |
| Accident Compensation Corporation NZCSD | 5,567,722 | 2.88% |
| Citibank Nominees (New Zealand) Limited NZCSD | 5,393,354 | 2.79% |
| FNZ Custodians Limited | 4,771,289 | 2.47% |
| HSBC Nominees A/C NZ Superannuation Fund Nominees Limited NZCSD | 4,218,386 | 2.18% |
| HSBC Custody Nominees (Australia) Limited | 3,881,197 | 2.01% |
| JBWere (NZ) Nominees Limited | 2,556,423 | 1.32% |
| ANZ Wholesale Australasian Share Fund NZCSD | 2,504,047 | 1.29% |
| New Zealand Depository Nominee Limited | 2,385,485 | 1.23% |
| Whyte Adder No 3 Limited | 1,797,874 | 0.93% |
| Generate Kiwisaver Public Trust nominees Limited <NZCSD> | 1,642,442 | 0.85% |
| Simplicity Nominees Limited NZCSD | 1,566,940 | 0.81% |